| JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | BIOTECNOLOGÍA | 17,44% | 1,11% | -23,87% | · |
| XTRACKERS MSCI CHINA UCITS ETF 1C | RVI CHINA | -3,33% | 12,14% | -23,93% | 57,31% |
| INVESCO GREATER CHINA EQUITY A CAP EUR (HEDGED) | RVI CHINA | 24,91% | 30,16% | -23,94% | 59,61% |
| FSSA CHINA A SHARES VI USD CAP | RVI CHINA | 17,22% | -1,98% | -23,95% | · |
| MSIF DEVELOPING OPPORTUNITY I (USD) | RVI EMERGENTES | -4,48% | 14,90% | -23,95% | · |
| BLUEBAY FUNDS - BLUEBAY EMERGING MARKET LOCAL CURRENCY BOND DR-GBP(QIDIV) | RFI EMERGENTES | 3,30% | 4,39% | -23,96% | -51,23% |
| FTGF BRANDYWINE GLOBAL FIXED INCOME X EUR (HEDGED) CAP | RFI GLOBAL | 1,96% | -1,76% | -23,96% | -23,41% |
| GOLDMAN SACHS ALL CHINA EQUITY PORTFOLIO R GBP DIS | RVI CHINA | 9,11% | 5,32% | -23,97% | 62,43% |
| SCHRODER ISF HONG KONG EQUITY C ACC EUR (HEDGED) | RVI CHINA | 14,43% | 3,00% | -23,97% | 50,77% |
| FIDELITY FUNDS-ASIAN BOND A-DIST-EUR (HEDGED) | RFI ASIA/OCEANÍA | -0,79% | -3,75% | -24,00% | -26,14% |
